FDA.reportPublic FDA data

NDC 73362-100-03 - Yorvipath

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
73362-100
Requested NDC
73362-100-03
Package NDCs from labels
73362-100-03, 73362-100-02, 73362-100-01
Manufacturer
Ascendis Pharma, Endocrinology, Inc.
Effective date
2026-08-12
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Yorvipath - Ascendis Pharma, Endocrinology, Inc.Ascendis Pharma, Endocrinology, Inc.2026-08-12HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
73362-100-01Yorvipath2 in 1 CARTONINJECTION, SOLUTION27
73362-100-02Yorvipath1 in 1 BOXINJECTION, SOLUTION17
73362-100-03Yorvipath0.56 mL in 1 CARTRIDGEINJECTION, SOLUTION0.567
73362-100-03Yorvipath1 in 1 SYRINGEINJECTION, SOLUTION17

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
73362-100YORVIPATH (PALOPEGTERIPARATIDE) INJECTION, SOLUTION [ASCENDIS PHARMA, ENDOCRINOLOGY, INC.]4Current NDC, 4 package rows20241019_a1fa23fd-c434-443e-9a17-5750578c8602.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
73362-100-01ML - Milliliter73362-100c94129f9-5215-4c55-bd4a-1a130d54416b12024-10-04
73362-100-03ML - Milliliter73362-1004f9f8263-9e1f-4fa9-b3a4-4aaefec2b0aa12024-10-04

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
YorvipathPALOPEGTERIPARATIDEAscendis Pharma, Endocrinology, Inc.a1fa23fd-c434-443e-9a17-5750578c86022026-08-12Warnings, Adverse reactionsExact identifier
application number: NDA216490
ndc (package): 73362-102-02
ndc (package): 73362-100-01
ndc (package): 73362-100-03
ndc (package): 73362-102-03
ndc (package): 73362-100-02
ndc (package): 73362-101-01
ndc (package): 73362-102-01
ndc (package): 73362-101-02
ndc (package): 73362-101-03
ndc (product): 73362-100
ndc (product): 73362-102
ndc (product): 73362-101
ndc11 (package): 73362010003
rxcui: 2693637
rxcui: 2693646
rxcui: 2693645
rxcui: 2693647
rxcui: 2693643
rxcui: 2693648
spl id: 93f0f8d6-548d-4961-bf87-565892563f0e
spl set id: a1fa23fd-c434-443e-9a17-5750578c8602
unii: G2N64C3385

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.